Cargando…
Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571949/ https://www.ncbi.nlm.nih.gov/pubmed/34841669 http://dx.doi.org/10.1002/ctm2.614 |
| _version_ | 1784595127093690368 |
|---|---|
| author | Yang, Chenxuan Liu, Jiaxiang Zhao, Shuangtao Ying, Jianming Liu, Yueping Ma, Li Shang, Qingyao Meng, Xiangzhi Feng, Kexin Zheng, Bo Guo, Changyuan Wang, Xin Wang, Xiang |
| author_facet | Yang, Chenxuan Liu, Jiaxiang Zhao, Shuangtao Ying, Jianming Liu, Yueping Ma, Li Shang, Qingyao Meng, Xiangzhi Feng, Kexin Zheng, Bo Guo, Changyuan Wang, Xin Wang, Xiang |
| author_sort | Yang, Chenxuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8571949 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85719492021-11-10 Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer Yang, Chenxuan Liu, Jiaxiang Zhao, Shuangtao Ying, Jianming Liu, Yueping Ma, Li Shang, Qingyao Meng, Xiangzhi Feng, Kexin Zheng, Bo Guo, Changyuan Wang, Xin Wang, Xiang Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-11-06 /pmc/articles/PMC8571949/ /pubmed/34841669 http://dx.doi.org/10.1002/ctm2.614 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Yang, Chenxuan Liu, Jiaxiang Zhao, Shuangtao Ying, Jianming Liu, Yueping Ma, Li Shang, Qingyao Meng, Xiangzhi Feng, Kexin Zheng, Bo Guo, Changyuan Wang, Xin Wang, Xiang Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer |
| title | Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer |
| title_full | Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer |
| title_fullStr | Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer |
| title_full_unstemmed | Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer |
| title_short | Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer |
| title_sort | establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐b breast cancer |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571949/ https://www.ncbi.nlm.nih.gov/pubmed/34841669 http://dx.doi.org/10.1002/ctm2.614 |
| work_keys_str_mv | AT yangchenxuan establishmentandvalidationofagasderminsignaturetoevaluatetheimmunestatusanddirectriskgroupclassificationinluminalbbreastcancer AT liujiaxiang establishmentandvalidationofagasderminsignaturetoevaluatetheimmunestatusanddirectriskgroupclassificationinluminalbbreastcancer AT zhaoshuangtao establishmentandvalidationofagasderminsignaturetoevaluatetheimmunestatusanddirectriskgroupclassificationinluminalbbreastcancer AT yingjianming establishmentandvalidationofagasderminsignaturetoevaluatetheimmunestatusanddirectriskgroupclassificationinluminalbbreastcancer AT liuyueping establishmentandvalidationofagasderminsignaturetoevaluatetheimmunestatusanddirectriskgroupclassificationinluminalbbreastcancer AT mali establishmentandvalidationofagasderminsignaturetoevaluatetheimmunestatusanddirectriskgroupclassificationinluminalbbreastcancer AT shangqingyao establishmentandvalidationofagasderminsignaturetoevaluatetheimmunestatusanddirectriskgroupclassificationinluminalbbreastcancer AT mengxiangzhi establishmentandvalidationofagasderminsignaturetoevaluatetheimmunestatusanddirectriskgroupclassificationinluminalbbreastcancer AT fengkexin establishmentandvalidationofagasderminsignaturetoevaluatetheimmunestatusanddirectriskgroupclassificationinluminalbbreastcancer AT zhengbo establishmentandvalidationofagasderminsignaturetoevaluatetheimmunestatusanddirectriskgroupclassificationinluminalbbreastcancer AT guochangyuan establishmentandvalidationofagasderminsignaturetoevaluatetheimmunestatusanddirectriskgroupclassificationinluminalbbreastcancer AT wangxin establishmentandvalidationofagasderminsignaturetoevaluatetheimmunestatusanddirectriskgroupclassificationinluminalbbreastcancer AT wangxiang establishmentandvalidationofagasderminsignaturetoevaluatetheimmunestatusanddirectriskgroupclassificationinluminalbbreastcancer |